Lankenau Heart Group consists of a team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons as well as specially-trained advance practice nurses and technologists. They're dedicated to managing and treating individuals with simple to complex cardiovascular disease, including heart failure, aortic disease, coronary artery disease, heart valve disease, peripheral artery disease and heart rhythm disorders. Our team of cardiac specialists provide patients and their families with expert heart care, close to home.
Services include:
- General cardiology
- Interventional cardiology
- Electrophysiology
- Heart failure
- Cardiac surgery
- Aortic surgery
Scheduling an appointment
Our office hours vary by physician and location. Please find a location in your neighborhood and schedule your appointment.
request an appointment online- After hours answering service available seven days a week
- Virtual care appointments available
- For times when you may require care outside of our operating hours, we offer access to urgent care services seven days a week and holidays
Insurance
We accept most insurance plans, including HMOs and PPOs.
Awards
Check. Change. Control. Cholesterol™ Participant
Lankenau Heart Group has received the American Heart Association's Check. Change. Control. Cholesterol™ Participant status. This award acknowledges the group's commitment to reducing the risk of heart disease and stroke through improved cholesterol management. It also recognizes practices that have committed to improving ASCVD risk assessment and submitted data on appropriate statin therapy.
TARGET: Type 2 Diabetes Gold Award
Lankenau Heart Group has received the American Heart Association's Target: Type 2 Diabetes Gold award for implementing quality improvement measures addressing the relationship between diabetes and cardiovascular disease in outpatient settings. The Gold award recognizes practices that have fulfilled the Participant criteria AND have met the gold level thresholds for each of two selected clinical measures related to diabetes control and CVD risk factors, hypertension and high cholesterol.
TARGET: BP™ Recognition Gold Award
Lankenau Heart Group has received the American Heart Association's Target: Type 2 Diabetes Gold award for implementing quality improvement measures addressing the relationship between diabetes and cardiovascular disease in outpatient settings. The Gold award recognizes practices that have fulfilled the Participant criteria AND have met the gold level thresholds for each of two selected clinical measures related to diabetes control and CVD risk factors, hypertension and high cholesterol. Lankenau Heart Group has been recognized by the American Heart Association (AHA) and American Medical Association (AMA) for their commitment to helping improve blood pressure (BP) control rates among the patient populations they serve, earning Gold level recognition as part of the 2021 Target: BP™ Recognition Program. The Gold award recognizes practices that have 70 percent or more of their adult patient population with high BP controlled.
